Loading…
Charting My Path for Future Success Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,674 other S bills in the 119th — cohort avg 32d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2026 · third_quarter · Health Issues
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target; H.R. 3514, the Improving Seniors' Timely Access to Care Act of 2025; Medicare drug pricing policy: Request for Information on policy options to lower prescription drug prices, decrease patient out-of-pocket expenses, and bolster biopharmaceutical innovation; HHS coverage and Medicare Payment on cardiovascular-Kidney-Metabolic syndrome; Centers for Medicare & Medicaid Services' (CMS) Proposed Decision Memorandum for Transcatheter Aortic Valve Replacement (TAVR)(comment); also contacted CMS to follow-up on previous ABC meetings.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS)
2026 · second_quarter · Health Issues
Access to care and improving cardiovascular health; FY27 Appropriations Bill; The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; H.R. 7417 / S. 3944, the Women's Heart Health Expansion Act of 2026; Meeting with Administrator of Centers for Medicare and Medicaid Services, regarding access to Transcatheter Aortic Valve Replacement (TAVR), Peripheral Artery Disease (PAD) screening, and LDL (bad cholesterol) target.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS)
2026 · first_quarter · Health Issues
Access to care and improving cardiovascular health Continuing Resolution, H.R. 1968 The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; The HEARTS Act, H.R. 6829; H.R. 307, the ARC Act of 2025; H.R. 1, One Big Beautiful Bill Act; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS)
2026 · first_quarter · Health Issues
Access to care and improving cardiovascular health Continuing Resolution, H.R. 1968 The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; The HEARTS Act, H.R. 6829; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; FY27 Appropriations Bill; H.R. 7417, Women's Heart Health Expansion Act of 2026; H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: Not reported · Firm income: $30,000
2025 · fourth_quarter · Health Issues
S.1261/HR 4206 - CONNECT For Health Act of 2025 - Supported permanent extension of existing telehealth flexibilities S. 932/HR 1262 - Give Kids a Chance Act - Supported extension of Rare Pediatric Disease Priority Review Voucher Program. HR 4249/S 2257 - FY 2026 Labor/HHS/Ed Appropriations - Funding for research, programs, and services for those with chronic diseases and disabilities HR 1 - Influencing implementation of Medicaid changes included in HR 1 HR 247 - eAPTC Permanent Reauthorization - Health Care Affordability Act of 2025 - Supported extension of ACA tax credits S. 2407 - The Treat and Reduce Obesity Act - Supported coverage for anti-obesity medications S. 2903/HR 5509 - The Safe Step Act - Supported passage of common-sense utilization management exceptions S. 1717/HR 5343 - Ensuring Patient Access to Critical Breakthrough Products Act - Supported faster coverage for breakthrough devices and diagnostics HR 3521 - Clinical Trials Modernization Act - Supported codifying clinical trial diversity processes
Client expense: $16,209 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Health Issues
Access to care and improving cardiovascular health Continuing Resolution, H.R. 1968 The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; The HEARTS Act, H.R. 6829; H.R. 307, the ARC Act of 2025; H.R. 1, One Big Beautiful Bill Act; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act
Client expense: Not reported · Firm income: $30,000
2025 · third_quarter · Health Issues
Access to care and improving cardiovascular health Continuing Resolution, H.R. 1968 The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; The HEARTS Act, H.R. 6829; H.R. 307, the ARC Act of 2025; H.R. 1, One Big Beautiful Bill Act; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act
Client expense: Not reported · Firm income: $30,000
2025 · second_quarter · Health Issues
Access to care and improving cardiovascular health Continuing Resolution, H.R. 10545 The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; The HEARTS Act, H.R. 6829; H.R. 307, the ARC Act of 2025; H.R. 1, One Big Beautiful Bill Act
Client expense: Not reported · Firm income: $30,000
2025 · first_quarter · Health Issues
Access to care and improving cardiovascular health Continuing Resolution, H.R. 10545 The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; The HEARTS Act, H.R. 6829; H.R. 307, the ARC Act of 2025
Client expense: Not reported · Firm income: $30,000